This page is an automatically generated summary of information from the Federal Court, Federal Court of Appeal, Health Canada and other websites. This information should NOT be relied upon as it is automatically generated and has not been confirmed for accuracy.
Automatically generated on July 6, 2024.
Return to the list of Patented Medicine Litigation page.
Filgrastim
NEUPOGEN – AMGEN CANADA INC (NOC Search)
Patents:
- 1297004: APOTEX
- 1297005: APOTEX
- 1340266: APOTEX
- 1341537: APOTEX, , TEVA
- 2006586: APOTEX
- 2006596: APOTEX
- 2178752: APOTEX
Unknown/Other
- PM(NOC) – T-741-18 (2018 FC 1078, 2020 FC 522)
APOTEX
- Appeal – A-501-15 (2016 FCA 121, 2016 FCA 196)
- PM(NOC) – T-1710-15 – T-2072-12 (2015 FC 1261)
TEVA
- PM(NOC) – T-989-12
Return to the Patented Medicine Litigation page.